And what the science really says about effective solutions
GLP-1 drugs are redefining the healthcare cost landscape, but most strategies to manage them are built on outdated assumptions. Let’s set the record straight.
The Myths
MYTH: “GLP-1s are a complete solution to the obesity crisis.”
REALITY
Without addressing daily behavior, many users stay dependent on these drugs indefinitely and the costs only compound over time.
WHAT IT MEANS
Medication without mindset change leads to a prolonged pharmacy (and cost) burden.
MYTH: “Coaching programs and point solutions drive long-term change.” (Noom, WW, etc.)
REALITY
Over 80–95% of users disengage from wellness apps within the first month—long before the 90-day mark. The brain doesn’t sustain change through pressure or performance. It builds
lasting habits through identity and iteration
WHAT IT MEANS
If your solution isn’t rooted in neuroscience, it’s built to fail.
MYTH: “Behavior change takes too long to make an impact.”
REALITY
Iterative Mindset Method shows measurable neural engagement within 8–10 weeks and habit retention rates 3x higher than industry norms.
WHAT IT MEANS
Sustainable doesn’t mean slow. It means real change.
What Smart Employers Do Differently
Leaders who get ahead of the GLP-1 cost curve are rethinking what actually works.
The difference? They understand behavior is the driver and neuroscience is the lever.
